Combined Transarterial Chemoembolization and Percutaneous Radiofrequency Ablation: More Promising Evidence of Effectiveness in Treating Solitary, Medium-Sized Hepatocellular Carcinoma.

作者： Ketan Y. Shah , Ron C. Gaba

关键词: Hepatocellular carcinoma 、 Radiofrequency ablation 、 Catheter ablation 、 Carcinoma 、 Radiology 、 Medicine 、 Percutaneous

摘要:

参考文章(31)

Chung-Mau Lo, Henry Ngan, Wai-Kuen Tso, Chi-Leung Liu, Chi-Ming Lam, Ronnie Tung-Ping Poon, Sheung-Tat Fan, John Wong, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. ,vol. 35, pp. 1164- 1171 ,(2002) , 10.1053/JHEP.2002.33156

Josep M Llovet, Maria Isabel Real, Xavier Montaña, Ramon Planas, Susana Coll, John Aponte, Carmen Ayuso, Margarita Sala, Jordi Muchart, Ricard Solà, Joan Rodés, Jordi Bruix, None, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial The Lancet. ,vol. 359, pp. 1734- 1739 ,(2002) , 10.1016/S0140-6736(02)08649-X

Riccardo Lencioni, Dania Cioni, Laura Crocetti, Chiara Franchini, Clotilde Della Pina, Jacopo Lera, Carlo Bartolozzi, Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation Radiology. ,vol. 234, pp. 961- 967 ,(2005) , 10.1148/RADIOL.2343040350

Ahsun Riaz, Robert J. Lewandowski, Laura Kulik, Robert K. Ryu, Mary F. Mulcahy, Talia Baker, Vanessa Gates, Ritu Nayar, Ed Wang, Frank H. Miller, Kent T. Sato, Reed A. Omary, Michael Abecassis, Riad Salem, Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. CardioVascular and Interventional Radiology. ,vol. 33, pp. 1143- 1152 ,(2010) , 10.1007/S00270-009-9766-5

Ju Hyun Shim, Seungbong Han, Yong Moon Shin, Eunsil Yu, Wonhyeong Park, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Optimal Measurement Modality and Method for Evaluation of Responses to Transarterial Chemoembolization of Hepatocellular Carcinoma Based on Enhancement Criteria Journal of Vascular and Interventional Radiology. ,vol. 24, pp. 316- 325 ,(2013) , 10.1016/J.JVIR.2012.10.022

Riccardo Lencioni, Thierry de Baere, Michael C. Soulen, William S. Rilling, Jean-Francois H. Geschwind, Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data Hepatology. ,vol. 64, pp. 106- 116 ,(2016) , 10.1002/HEP.28453

Young-sun Kim, Hyo Keun Lim, Hyunchul Rhim, Min Woo Lee, Dongil Choi, Won Jae Lee, Seung Woon Paik, Kwang Cheol Koh, Joon Hyeok Lee, Moon Seok Choi, Geum-Youn Gwak, Byung Chul Yoo, Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors Journal of Hepatology. ,vol. 58, pp. 89- 97 ,(2013) , 10.1016/J.JHEP.2012.09.020

John P. McGahan, Gerald D. Dodd, Radiofrequency ablation of the liver: current status. American Journal of Roentgenology. ,vol. 176, pp. 3- 16 ,(2001) , 10.2214/AJR.176.1.1760003

David S. K. Lu, Nam C. Yu, Steven S. Raman, Piyaporn Limanond, Charles Lassman, Kathryn Murray, Myron J. Tong, Rafael G. Amado, Ronald W. Busuttil, Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. ,vol. 234, pp. 954- 960 ,(2005) , 10.1148/RADIOL.2343040153